Amprion values its research partners for their commitment and dedication to science. We stand united on a single mission–finding cures for brain diseases.
We’re known by the company we keep. These research partners joined Amprion on the path of making scientific breakthroughs in neurodegenerative diseases.
A pioneer in the science of detecting misfolded proteins, Amprion advances the diagnosis of brain disorders. Our SAAmplify™-ɑSYN Test aids physicians in diagnosing Parkinson’s, Lewy body dementia, and Alzheimer’s with Lewy body variant. We plan to launch more biomarker tests in the future.
Our flagship α-synuclein SAA, SYNTap®, is getting a makeover.
Effective September 9, 2024, SYNTap will be
And stay tuned for the SAAmplify family of panels, coming soon!
